Some patients experience palpitations, a fluttering sensation in the chest, or feelings of nervousness and shakiness
In the case of more serious causes such as colon cancer, major surgery and additional treatment are necessary
How will these moves impact the weight-loss drugs segment in India
In a comparison between GLP-1RAs and SGLT2 inhibitors, 105,794 patients were included in the GLP-1RA cohort, and 69,826 patients were in the SGLT2 inhibitor cohort
Headquartered in Tel Aviv, Teva is the world's largest generic pharmaceutical company and a significant specialty innovator, with a particular position in the peptide therapy market through Copaxone (glatiramer acetate) a synthetic peptide copolymer that has been the world's best-selling multiple sclerosis treatment for two decades and AJOVY (fremanezumab), a CGRP-targeting monoclonal antibody for migraine prevention that occupies the neurological peptide signalling space
This neural mechanism explains why many patients report sustained weight loss and improved dietary habits with GLP-1 therapy, even after treatment ends
